Enservco Reports 2020 Second Quarter and Six-Month Financial Results
Company Updates Investors on Progress Toward Refinancing Debt, Including Recent East West Bank Grant of 45 Day Extension to Senior […]
Front Yard Residential Announces Termination of Asset Management Agreement with AAMC
CHRISTIANSTED, U.S. Virgin Islands, Aug. 14, 2020 (GLOBE NEWSWIRE) — Front Yard Residential Corporation (“Front Yard” or the “Company”) (NYSE: […]
Altisource Asset Management Corporation Reports Second Quarter 2020 Results; Announces Agreement to Terminate the Asset Management Agreement between AAMC and Front Yard Residential Corporation
CHRISTIANSTED, U.S. Virgin Islands, Aug. 14, 2020 (GLOBE NEWSWIRE) — Altisource Asset Management Corporation (“AAMC” or the “Company”) (NYSE American: […]
DSS Announces Second Quarter 2020 Financial Results
ROCHESTER, N.Y., Aug. 14, 2020 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a […]
American Shared Hospital Services Reports Second Quarter 2020 Financial Results
COVID-19 Pandemic Had Significant Impact on Q2 VolumesSAN FRANCISCO, CA, Aug. 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — American […]
BIO-key Reports Q2 Results and a Post-Recapitalization Cash Position of Approximately $18M – Investor Webcast Today at 10am ET
WALL, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and other […]
Cancer Genetics Reports Second Quarter 2020 Financial Results
RUTHERFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery […]
Nephros Names Andy Astor President and Chief Executive Officer
Daron Evans to Remain Senior Science Advisor and CEO of Specialty Renal ProductsSOUTH ORANGE, NJ, Aug. 14, 2020 (GLOBE NEWSWIRE) […]
ContraFect Reports Second Quarter 2020 Financial Results and Provides Business Update
Exebacase Phase 2 study results published in the Journal of Clinical InvestigationContinued patient enrollment in ongoing Phase 3 DISRUPT study […]
Ocugen Provides Business Update and Second Quarter 2020 Financial Results
Two Additional Orphan Drug Designations Granted for OCU400 Modifier Gene Therapy ProgramConference Call and Webcast Today at 8:30 a.m. ETMALVERN, […]
